FINWIRES · TerminalLIVE
FINWIRES

Elbit Systems' First-Quarter Results Rise as Order Backlog Tops $30 Billion

By
Elbit Systems' First-Quarter Results Rise as Order Backlog Tops $30 Billion

Elbit Systems (ESLT) reported higher first-quarter results and said its order backlog topped $30 billion, lifted by surging demand from Israel's Ministry of Defense amid ongoing regional conflicts.

The Israeli defense electronics company on Tuesday reported non-GAAP per-share earnings in the three months ended March 31 rose to $3.87 from $2.57 a year earlier. Four analysts in a FactSet poll projected $3.38. Revenue increased to $2.19 billion from $1.9 billion. Three analysts expected $2.15 billion.

The company's shares jumped 8.4% in Tuesday trading in New York. The stock has advanced 44% this year.

"We began 2026 with a strong quarter across all key metrics, including double-digit growth in revenue and profitability, with non-GAAP operating margins surpassing the 10% mark," CEO Bezhalel Machlis said in a statement.

Elbit reported a record order backlog of $30.2 billion at the end of March, with about 71% outside of Israel.

The company cited a "continued material increase" in demand for its products and solutions from Israel amid the war in Iran and other conflicts in the Middle East. The war is now in its third month, with the US reportedly launching fresh strikes on Iran on Monday.

"With demand rising well above historical levels, we continue to focus on order execution," Machlis said. "We are scaling production capacity, increasing the use of automation, robotics and AI, while maintaining strict capital discipline and expanding operational margins."

Elbit won a $1.4 billion contract covering a European customer's extensive military modernization programs. It includes the delivery of uncrewed autonomous solutions, advanced networked land electronic warfare, and precision-guided munitions, the company said Tuesday in a separate statement.

Land revenue in the first quarter rose 27% to $714.6 million, buoyed by ammunition sales in Israel and Europe. Revenue in the command, control, communications, computers and intelligence and cyber business climbed 17% to $256.7 million, driven by sales in Europe.

Intelligence, surveillance, target acquisition and reconnaissance and electronic warfare revenue increased 17% to $423.1 million, and aerospace revenue rose 2% to $516.6 million. Elbit Systems of America revenue gained 5% to $423.9 million.

Price: $832.33, Change: $+64.51, Percent Change: +8.40%

Related Articles

AutoZone Posts Mixed Fiscal Third-Quarter Results
US Markets

AutoZone Posts Mixed Fiscal Third-Quarter Results

AutoZone (AZO) reported mixed fiscal third-quarter results on Tuesday, with earnings topping market estimates and revenue falling short.The auto parts retailer posted net income of $38.07 a share for the three months through May 9, up from $35.36 the year before. The consensus on FactSet was for EPS of $36.21. Sales rose to $4.84 billion from $4.46 billion, but missed the Street's view for $4.86 billion.Shares of the company plunged 9.5% in Tuesday trade.Same-store sales increased 5.5%, topping the average analyst estimate for a 5.3% gain.AutoZone's domestic growth slowed to 4.1% in the third quarter from 5% in the prior-year period. The print likely came in at the lower end of investor expectations that ranged from 4% to 5%, Truist Securities said in a client note.Domestically, both do-it-yourself and commercial sales grew "impressively," Chief Executive Phil Daniele said in a statement. However, Truist Managing Director Scot Ciccarelli said "the DIY segment is still pressured due to economic issues/gas prices."Gasoline prices in the US have surged as the Middle East conflict pushed crude oil costs higher due to the effective closure of the Strait of Hormuz.Last week, Advance Auto Parts (AAP) reported comparable sales growth of 3.5% for its first quarter. Ciccarelli said it was against a "much easier" comparison and that Advance Auto Parts has "significantly more exposure" to the faster-growing commercial segment.Truist still expects AutoZone to gain market share in the "favorable" do-it-yourself vertical, where it has more exposure than peers."While international performance has been below our plan, we believe our market share continues to grow," Daniele said.Price: $3122.97, Change: $-283.53, Percent Change: -8.32%

$AZO
Eli Lilly to Acquire Three Vaccine Developers for Up to $3.83 Billion
US Markets

Eli Lilly to Acquire Three Vaccine Developers for Up to $3.83 Billion

Eli Lilly (LLY) will acquire three vaccine developers in all-cash deals with a combined value of up to $3.83 billion, as the drugmaker aims to strengthen its infectious disease portfolio.The pharmaceutical giant on Tuesday agreed to purchase Curevo for up to $1.5 billion, LimmaTech Biologics for up to $780 million and Vaccine Company for up to $1.55 billion, including upfront and subsequent payments upon meeting certain milestones. Eli Lilly's shares were up 1.2% in the most recent premarket activity.The transactions will expand the company's research and development efforts in infectious diseases and reflect its strategy of investing in differentiated technology platforms, it said."These acquisitions reflect a deliberate strategy to prevent disease at its source rather than treat its consequences," Eli Lilly Chief Scientific and Product Officer Daniel Skovronsky said in a statement. "Combining these companies' platforms and teams with Lilly's global scale positions us to change that trajectory."The acquisition of Curevo will give Eli Lilly access to its lead product candidate, amezosvatein, which is currently being developed for the prevention of shingles in adults. "Lilly's global development and commercialization capabilities will accelerate and expand upon amezosvatein's significant potential," Curevo Chief Executive George Simeon said in a separate statement.Switzerland-based LimmaTech is developing vaccines against bacterial pathogens, with its LTB-SA7 lead program currently in phase 1 development as a vaccine against staphylococcus aureus. Vaccine Company's lead program is applying in vivo nanoparticle technologies to the Epstein-Barr virus, with a five-antigen phase 1-ready candidate.Last month, Eli Lilly agreed to acquire clinical-stage biotechnology firm Kelonia Therapeutics for up to $7 billion to bolster its cancer treatment portfolio. Earlier in the year, Lilly announced an up to $7.8 billion deal to purchase UK-based Centessa Pharmaceuticals and also agreed to buy Orna Therapeutics, a biotechnology company focused on engineering immune cells, for up to $2.4 billion.In April, the drugmaker raised its full-year outlook and reported better-than-expected first-quarter results.

$LLY
Update: Google Seeks Resolution to EU Antitrust Probe Amid Reports of Record Fine
US Markets

Update: Google Seeks Resolution to EU Antitrust Probe Amid Reports of Record Fine

(Updates stock movement and adds statement from the European Commission)Alphabet's (ABEA.F) Google said Tuesday it is "keen" to resolve an ongoing antitrust probe by the European Union after reports emerged that Brussels is preparing to impose its largest-ever penalty for suspected violations of the bloc's Digital Markets Act."We are keen to bring this investigation to a close so we can get back to developing innovative products for our users," a Google spokesperson told. "The changes we've already made to Search under the DMA represent the biggest downgrade in the product's history, creating a second-rate experience for Europeans to the benefit of a few self-interested complainants."Meanwhile, a European Commission spokesperson told MT that the body is having "extensive discussions" with Google on future compliance solutions, saying that simply issuing a fine "formalises the infringement without solving the issue at hand.""Even with our negotiations on future solutions, we will not hesitate to move to the next steps as soon as possible," the spokesperson said.Launched in March 2025, the investigation into an alleged breach of the DMA focused on concerns that Google prioritized its own services within search results. The probe was part of broader efforts by the European Commission to ensure the tech company complied with local laws.The fine is projected to reach the high hundreds of millions of euros and will likely be finalized before the summer recess, Germany's Handelsblatt newspaper reported Monday, citing sources at the European Commission. The sources noted that European Commission President Ursula von der Leyen holds the final authority on the exact amount of the fine.Earlier in May, EU regulators gave Google "a bit more time" to address the antitrust concerns after its initial proposals were deemed "simply not strong enough," according to European Commission spokesperson Thomas Regnier.Alphabet's Frankfurt-listed stock was over 2% in the red by Tuesday afternoon.

$ABEA.F